MedPath

Combination Dexamethasone and Bupivacaine Pain Control in Reduction Mammaplasty

Phase 2
Completed
Conditions
Mammaplasty
Pain, Postoperative
Interventions
Registration Number
NCT04919317
Lead Sponsor
Temple University
Brief Summary

The addition of dexamethasone to non-liposomal bupivacaine in perineural blocks has been shown to enhance pain control and prolong the time until first request for postoperative narcotics in the fields of orthopedic, thoracic, and gynecologic surgery. This has not been investigated in any types of breast surgery. The investigators assessed if the combination of dexamethasone to bupivacaine in the preoperative field block prior to bilateral breast reduction surgery resulted in improved pain control relative to bupivacaine alone.

Detailed Description

The investigators conducted a double-blind randomized controlled trial to determine whether the addition of dexamethasone to bupivacaine in a preoperative Pecs II block resulted in improved pain control, relative to bupivacaine alone, in patients undergoing bilateral reduction mammaplasty.

Using a preassigned randomization list, patients were randomized to experimental and control groups in a ratio of 1:1 upon enrollment. Both groups received PECS II bupivacaine field blocks in the preoperative holding area, performed by an acute pain fellowship-trained anesthesiologist. The experimental group received 29mL of 0.5% bupivacaine mixed with 1mL 4mg/mL dexamethasone per side. The control group received 29mL 0.5% bupivacaine mixed with 1mL 0.9 saline solution per side. To maintain the blinded aspect of the study, the anesthesiologists were given pre-mixed vials labelled uniformly for the trial, regardless of the patient's treatment arm.

The patients all underwent bilateral breast reduction with a single surgeon. Postoperative pain regimens were standardized. Subjective pain scores, narcotic consumption, 4-hour interval vital signs, anti-emetic usage, and postoperative quality of life via an sf-36 questionnaire were all recorded per patient.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
56
Inclusion Criteria
  • Female
  • Age 18-80
  • Bilateral reduction mammaplasty
  • American Society of Anesthesiologists (ASA) physical status classification 1, 2, or 3
  • Must choose to receive preoperative nerve block as part of pain management strategy
Exclusion Criteria
  • Allergy to dexamethasone or bupivacaine
  • History of postoperative nausea and vomiting following anesthesia
  • History of chronic pain conditions
  • History of narcotic abuse or dependency
  • History of chronic renal disease
  • History of chronic liver disease

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
ExperimentalDexamethasone 4mgExperimental group patients received 29mL bupivacaine plus 1mL of 4mg/mL dexamethasone. Like the control group, 20mL of the mixture was injected into the fascial plane between the pectoralis minor and the serratus anterior muscles at the level of the third rib, while the remaining 10mL of the mixture was then injected into the fascial plane between the pectoralis major and pectoralis minor muscles during the same needlestick.
ControlSalineControl group patients received 29mL bupivacaine plus 1mL 0.9% saline. Like the experimental group, 20mL of the mixture was injected into the fascial plane between the pectoralis minor and the serratus anterior muscles at the level of the third rib, while the remaining 10mL of the mixture was then injected into the fascial plane between the pectoralis major and pectoralis minor muscles during the same needlestick.
Primary Outcome Measures
NameTimeMethod
16-hour Visual Analog Scale (VAS) Pain ScoresRecorded at 16-hours after arrival to the post-anesthesia recovery unit (PACU)

Patient-reported pain scores on a scale of 1-10 (1 is low or no pain and 10 is the highest amount of pain)

8-hour Visual Analog Scale (VAS) Pain ScoresRecorded at 8-hours after arrival to the post-anesthesia recovery unit (PACU)

Patient-reported pain scores on a scale of 1-10 (1 is low or no pain and 10 is the highest amount of pain)

12-hour Visual Analog Scale (VAS) Pain ScoresRecorded at 12-hours after arrival to the post-anesthesia recovery unit (PACU)

Patient-reported pain scores on a scale of 1-10 (1 is low or no pain and 10 is the highest amount of pain)

Narcotic ConsumptionUp to 24 hours postoperatively

Mean narcotics used by each patient while in the hospital during the 24-hour hospitalization

4-hour Visual Analog Scale (VAS) Pain ScoresRecorded at 4-hours after arrival to the post-anesthesia recovery unit (PACU)

Patient-reported pain scores on a scale of 1-10 (1 is low or no pain and 10 is the highest amount of pain)

Initial Visual Analog Scale (VAS) Pain ScoresRecorded immediately upon arrival to the post-anesthesia recovery unit (PACU)

Patient-reported pain scores on a scale of 1-10 (1 is low or no pain and 10 is the highest amount of pain)

20-hour Visual Analog Scale (VAS) Pain ScoresRecorded at 20-hours after arrival to the post-anesthesia recovery unit (PACU)

Patient-reported pain scores on a scale of 1-10 (1 is low or no pain and 10 is the highest amount of pain)

24-hour Visual Analog Scale (VAS) Pain ScoresRecorded at 24-hours after arrival to the post-anesthesia recovery unit (PACU)

Patient-reported pain scores on a scale of 1-10 (1 is low or no pain and 10 is the highest amount of pain)

Secondary Outcome Measures
NameTimeMethod
24-hour Blood PressureRecorded at 24-hours after arrival to the post-anesthesia recovery unit (PACU)

Systolic blood pressure

8-hour Blood PressureRecorded at 8-hours after arrival to the post-anesthesia recovery unit (PACU)

Systolic blood pressure

20-hour Blood PressureRecorded at 20-hours after arrival to the post-anesthesia recovery unit (PACU)

Systolic blood pressure

Initial Blood PressureRecorded immediately upon arrival to the post-anesthesia recovery unit (PACU)

Systolic blood pressure

16-hour Blood PressureRecorded at 16-hours after arrival to the post-anesthesia recovery unit (PACU)

Systolic blood pressure

Initial Oxygen SaturationRecorded immediately upon arrival to the post-anesthesia recovery unit (PACU)

SpO2 as measured by pulse oximetry

12-hour Blood PressureRecorded at 12-hours after arrival to the post-anesthesia recovery unit (PACU)

Systolic blood pressure

8-hour Oxygen SaturationRecorded at 8-hours after arrival to the post-anesthesia recovery unit (PACU)

SpO2 as measured by pulse oximetry

12-hour Oxygen SaturationRecorded at 12-hours after arrival to the post-anesthesia recovery unit (PACU)

SpO2 as measured by pulse oximetry

Number of Patients Administered Anti-emetics at 4-hour IntervalsInitial, 4, 8, 12, 16, 20, and 24 hours

Frequency of anti-emetics administered for complaints of nausea or vomiting at 4-hour intervals

Short-form 36-item (Sf-36) Quality of Life Questionnaire1 week to 2 months postoperatively

Aggregate results of the sf-36 quality of life assessment. This was provided one time to each patient, as early as at the first postoperative visit or at any time thereafter up to 2 months postoperatively. This assessment has been validated to measure 8 categories related to quality of life: physical functioning, limitations due to physical health, limitations due to emotional health, perceived level of energy/fatigue, emotional well-being, social functioning, pain, and overall general health. The responses to the 36 questions are tabulated and each category is given a score from 1-100 for each individual patient. Higher scores indicate a better quality of life for that category. The rows/data below report the mean and standard deviations of the collected scores in each category.

Rate of Wound Complications1 week to 2 months postoperatively

Assessment of wound complications during any postoperative clinic visit

4-hour Blood PressureRecorded at 4-hours after arrival to the post-anesthesia recovery unit (PACU)

Systolic blood pressure

4-hour Oxygen SaturationRecorded at 4-hours after arrival to the post-anesthesia recovery unit (PACU)

SpO2 as measured by pulse oximetry

16-hour Oxygen SaturationRecorded at 16-hours after arrival to the post-anesthesia recovery unit (PACU)

SpO2 as measured by pulse oximetry

20-hour Oxygen SaturationRecorded at 20-hours after arrival to the post-anesthesia recovery unit (PACU)

SpO2 as measured by pulse oximetry

24-hour Oxygen SaturationRecorded at 24-hours after arrival to the post-anesthesia recovery unit (PACU)

SpO2 as measured by pulse oximetry

Trial Locations

Locations (1)

Temple University Hospital

🇺🇸

Philadelphia, Pennsylvania, United States

© Copyright 2025. All Rights Reserved by MedPath